Characterization of Mycobacterium tuberculosis in Syrian patients by double-repetitive-element polymerase chain reaction;Caractérisation de Mycobacterium tuberculosis par PCR d'éléments répétitifs doubles chez des patients syriens

Eastern Mediterranean Health Journal

Volumn 16, Issue 8, 2010, Pages 820-830

  Rahmo, A ^a   Hamze, M ^b  

^a National Commission for Biotechnology   (Syrian Arab Republic)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DNA EXTRACTION; DNA STRUCTURE; DOUBLE REPETITIVE ELEMENT POLYMERASE CHAIN REACTION; FEMALE; GENE INSERTION SEQUENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; POLYMORPHIC GC RICH REPEAT; REPETITIVE DNA ELEMENT; SCHOOL CHILD; SEX DIFFERENCE; SYRIAN ARAB REPUBLIC;

EID: 77955778258     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.8.820     Document Type: Article

References (29)

1. Tanaka MM. Evidence for positive selection on Mycobacterium tuberculosis within patients. BMC Evolutionary Biology, 2004, 4:31 (doi: 10.1186/1471-2148-4-3).
2. Zigol M et al. Patients with previously treated tuberculosis no longer neglected. Clinical Infectious Diseases, 2007, 44:61-64.
3. Verver S et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. American Journal of Respiratory and Critical Care Medicine, 2005, 171:1430-1435.
4. Martínez M et al. Impact of laboratory cross-contamination on molecular epidemiology studies of tuberculosis. Journal of Clinical Microbiology, 2006, 44(8):2967-2969.
5. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerging Infectious Diseases, 2006, 12(5):736-743.
6. Montoro E et al. Molecular fingerprinting of Mycobacterium tuberculosis isolates obtained in Havana, Cuba, by IS6110 restriction fragment length polymorphism analysis and by the double-repetitive-element PCR method. Journal of Clinical Microbiology, 1998, 36:3099-3102.
7. Sola C et al. Spoligotyping followed by double-repetitiveelement PCR as a rapid alternative to IS6110 fingerprinting for epidemiological studies in tuberculosis. Journal of Clinical Microbiology, 1998, 36:1122-1124.
8. Kubica GP et al. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. American Review of Respiratory Disease, 1963, 78:775-779.
9. Antimycobacterial susceptibility testing for Mycobacterium tuberculosis. Tentative standard M24-T. Villanova, Pennsylvania, National Committee for Clinical Laboratory Standards, 2002.
10. Harris E. A low-cost approach to PCR, appropriate transfer of biomolecular techniques. Oxford, Oxford University Press, 1998.
11. Friedman CD et al. Double-repetitive-element PCR method for subtyping Mycobacterium tuberculosis clinical isolates. Journal of Clinical Microbiology, 1995, 33:1383-1384.
12. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. Journal of Clinical Microbiology, 1998, 26:2465-2466.
13. Countries. World Health Organization [website] (http://www.who.int/countries/en/, accessed 5 January 2010).
14. Karim F et al. Gender differences in delays in diagnosis and treatment of tuberculosis. Health Policy and Planning, 2007, 22(5):329-324.
15. Pérez-Guzmán C et al. Diabetes modifies the male: female ratio in pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease, 2003, 7(4):354-358.
16. Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression of Toll-like receptor 4 in the mouse, a trigger for inflammation and innate immunity. Biology of Reproduction, 2008, 78(3):432-437.
17. Razanamparany VR et al. Extrapulmonary and pulmonary tuberculosis in Antananarivo (Madagascar): high clustering rate in female patients. Journal of Clinical Microbiology, 2002, 40(11):3964-3969.
18. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1998-1999: report of the Australian Mycobacterium Reference Laboratory Network. Communicable Diseases Intelligence, 2001, 25(4):261-265.
19. Pym AS, Saint-Joanis B, Cole ST. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infection and Immunity, 2002, 70(9):4955-4960.
20. Shen X et al. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 2007, 51(7):2618-2620.
21. Hazbo'n MH et al. Role of embB Codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrobial Agents and Chemotherapy, 2005, 49(9):3794-3802.
22. Colangeli, R et al. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Molecular Microbiology, 2005, 55(6):1829-1840.
23. Tanaka MM, Rosenberg NA, Small PM. The control of copy number of IS6110 in Mycobacterium tuberculosis. Molecular Biology and Evolution, 2004, 21:2195-2201.
24. Farnia P et al. Instability of IS6110 patterns in multidrug-resistant strains of Mycobacterium tuberculosis. Epidemiology and Infection, 2007, 135:346-352.
25. Beggs ML, Eisenach KD, Cave MD. Mapping of IS6110 insertion sites in two epidemic strains of Mycobacterium tuberculosis. Journal of Clinical Microbiology, 2000, 38(8):2923-2928.
26. Safi H et al. IS6110 functions as a mobile, monocyte-activated promoter in Mycobacterium tuberculosis. Molecular Microbiology, 2004, 52(4):999-1012.
27. Gey van Pittius NC et al. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evolutionary Biology, 2006, 6:95 (doi: 10.1186/1471-2148-6-95).
28. Gillespie SH. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrobial Agents and Chemotherapy, 2002, 46(2):267-274.
29. Hanekom M et al. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. Journal of Clinical Microbiology, 2007, 45(5):1483-1490.